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ABBREVIATIONS
FOA Fronto-orbital advancement
ICH Intracranial hypertension
OCT Optical coherence tomography
OFC Occipital frontal head
circumference
OSA Obstructive sleep apnoea
AIM To assess the long-term outcomes of our management protocol for Saethre–Chotzen
syndrome, which includes one-stage fronto-orbital advancement.
METHOD All patients born with Saethre–Chotzen syndrome between January 1992 and March
2017 were included. Evaluated parameters included occipital frontal head circumference
(OFC), fundoscopy, neuroimaging (ventricular size, tonsillar position, and the presence of
collaterals/an abnormal transverse sinus), polysomnography, and ophthalmological
outcomes. The relationship between papilledema and its associated risk factors was
evaluated with Fisher’s exact test.
RESULTS Thirty-two patients (21 females, 11 males) were included. Median (SD) age at first
surgery was 9.6 months (3.1mo) for patients who were primarily referred to our center
(range: 3.6–13.0mo), the median (SD) age at last follow-up was 13 years (5y 7mo; range: 3–
25y). Seven patients had papilledema preoperatively, which recurred in two. Two patients
had papilledema solely after first surgery. Second cranial vault expansion was indicated in
20%. Thirteen patients had an OFC deflection, indicating restricted skull growth, one patient
had ventriculomegaly, and none developed hydrocephalus. Eleven patients had emissary
veins, while the transverse sinus was aberrant unilaterally in 13 (hypoplastic n=10 and absent
n=3). Four patients had mild tonsillar descent, one of which was a Chiari type I malformation.
Four patients had obstructive sleep apnoea (two mild, one moderate, and one severe). An
aberrant transverse sinus was associated with papilledema (p=0.01).
INTERPRETATION Single one-stage fronto-orbital advancement was sufficient to prevent
intracranial hypertension for 80% of our patients with Saethre–Chotzen syndrome. Follow-up
should focus on OFC deflection and venous anomalies.
Saethre–Chotzen syndrome is a craniosynostosis syndrome,
which arises in 1 per 100 000 live births.1 Its clinical fea-
tures include uni- or bicoronal synostosis, low hairline,
external ear abnormalities, ptosis of the upper eyelid(s),
tear duct stenosis, hypertelorism and anomalies of the hand
(such as syndactyly and brachydactyly), and short stature.2,3
Clinical diagnosis in these patients is genetically confirmed
by a deletion or mutation in the TWIST1 gene.4-6
The management of patients with Saethre–Chotzen syn-
drome consists of a multidisciplinary approach, and focuses
on several aspects regarding child development such as
hearing capacity; speech, language, and neuropsychological
development; vision; dental outcomes; and management of
the airway. Additionally, prevention of intracranial hyper-
tension (ICH) is a major goal. Literature on the presence,
causes, and treatment of ICH in patients with Saethre–
Chotzen syndrome is limited. The reported prevalence of
ICH before surgery, defined by papilledema on fundoscopy
or by ICH on intraparenchymal measurement, varies
between 19% and 35%.2,7 Occurrence of ICH after vault
expansion is reported in 17% to 42% of patients,3,7 which
is remarkably lower than reported for patients with Apert
and Crouzon syndromes.7,8 Our preferred surgical treat-
ment for Saethre–Chotzen syndrome is a single fronto-or-
bital advancement (FOA) for three reasons: (1) second
cranial vault expansion is seldom indicated, (2) there is no
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anticipated need for mid-face advancement in the future,
which is more complicated after an FOA, and (3) FOA
restores the distorted facial profile.
The aim of this study was to evaluate the long-term out-
come of our management protocol for patients with
Saethre–Chotzen syndrome by determining the prevalence
of ICH and its risk factors.
METHOD
Participants
All patients with Saethre–Chotzen syndrome born between
1992 and 2017, who were treated at the Dutch Craniofa-
cial Center (Erasmus University MC – Sophia Children’s
Hospital, Rotterdam, the Netherlands), were included in
this study. Children born after 2005 were prospectively
included and children born before 2005 were retrospec-
tively included. Patients with unavailable data for more
than three variables (see below) were excluded. The study
was approved by the ethics committee of Erasmus MC
(MEC-2005-273 and MEC-2016-312). All patients were
genetically tested, and since the phenotype was clear in the
majority of patients, genetic testing included targeted
sequencing of the TWIST1 gene, and additional fluores-
cence in situ hybridization or multiplex ligation-dependent
probe amplification in patients with a suspected deletion
in, or of, the TWIST1 gene. In some patients, the FGFR3
gene (P250R mutation) was also tested.
According to our protocol, routine FOA was performed
at the age of 6 to 9 months, with remodelling and advance-
ment of the forehead and supra-orbital bar.9,10 The orbital
rim was advanced approximately 1.5cm, thereby taking into
consideration that the facial profile should not be signifi-
cantly disturbed.
ICH
Patients were screened for the presence of ICH according
to our standardized management protocol,10 which
includes assessment of: bulging of the fontanel in calm
infants; monitoring of symptoms suggestive of ICH, such
as morning headaches and behavioural changes; skull
growth: occipital frontal head circumference (OFC) was
measured preoperatively, every 3 months until the age of 2
years, every 6 months until the age of 4 years, and from
then on annually, and was used as an indicator for intracra-
nial volume;11 growth curve deflection, defined preopera-
tively as at least a 0.5 SD fall from baseline and the
postoperative baseline established 1 year after surgery
defined as at least a 0.5 SD fall from the renewed baseline;
fundoscopy: to screen for papilledema, performed once
preoperatively, at the ages of 2, 4, and 6 years, and addi-
tionally as indicated (pseudopapilledema caused by high
hypermetropia was excluded);12 and optical coherence
tomography (OCT) in children aged at least 4 years, using
a Spectralis OCT scanner (Heidelberg Engineering, Hei-
delberg, Germany). The latter was added to the protocol
in 2014. The total retinal thickness was analysed using our
normative references, which were derived from OCT data
of 67 typically developing children (aged 4–12y). Abnormal
values included total retinal thickness of less than 276µm
or greater than 503µm (unpublished material, van de Bee-
ten et al.), indicating either atrophy or papilledema.
Invasive intracranial pressure monitoring was performed
when ICH was suspected, despite the absence of papille-
dema on repeated fundoscopy with a 6-week interval. This
24-hour examination was evaluated according to the fol-
lowing criteria.13 (1) Baseline intracranial pressure during
the day and overnight: less than 10mmHg, normal;
10mmHg to 15mmHg, borderline abnormal depending on
the height and duration of abnormal plateaus; and greater
than 15mmHg, abnormal. Additionally, the trend of
intracranial pressure values was evaluated to check for any
increase overnight. (2) Number of abnormal plateau waves:
based on height (<25mmHg, normal; 25–35mmHg, bor-
derline; and >35mmHg, abnormal) and duration (<10mins,
normal; 10–20mins, borderline; and >20mins, abnormal).
Patients with papilledema and/or abnormal intracranial
pressure measurements were all considered to have ICH.
Neuroimaging
The presence of tonsillar herniation, venous collaterals,
and transverse sinuses was reviewed on magnetic resonance
imaging (MRI) scans, while ventricular size was evaluated
on MRI and computed tomography (CT) scans. A three-
dimensional reformatting platform (AquariusNET; TeraR-
econ Inc., Melbourne, Victoria, Australia) was used to
align scans in all planes. CT and MRI studies were part of
the standard care protocol.
The presence and extent of tonsillar herniation was eval-
uated on mid-sagittal and adjacent slices and was classified
as: (1) no tonsillar descent, (2) tonsillar descent less than
5mm, or (3) herniation greater than 5mm (i.e. Chiari type
I malformation). The position of the lowest tonsil relative
to the foramen magnum was measured.
Occipital emissary veins were scored on CT angiogra-
phy/MRI scans and were classified as either absent or pre-
sent. The transverse sinuses were scored as normal,
hypoplastic, or absent.
The frontal occipital horn ratio was measured on axial
planes to evaluate the sizes of the lateral ventricles. A fron-
tal occipital horn ratio greater than 0.34 indicated enlarged
ventricles.14 Hydrocephalus was defined as progressive
enlargement of the ventricles on two or more MRI or CT
scans.
Sleep studies
Clinical and ambulant sleep studies were used to diagnose
obstructive sleep apnoea (OSA). All sleep studies were
scored according to the 2012 update of the American
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Association of Sleep Medicine.15 The obstructive apnoea–
hypopnea index was calculated by adding the number of
obstructive apnoeas, mixed apnoeas, and obstructive
hypopneas with desaturation/arousal, divided by the total
sleep time. Arousals could only be scored on clinical sleep
studies. Patients were subdivided in either mild (obstruc-
tive apnoea–hypopnoea index ≥1 and <5), moderate (ob-
structive apnoea–hypopnoea index ≥5 and <10), or severe
(obstructive apnoea–hypopnoea index ≥10) OSA groups.
Analysis of proportional differences
To evaluate proportional differences between patients who
underwent one versus two or more cranial vault expan-
sions, one-tailed Fisher’s exact tests were used, given that
the direction of the effect was anticipated. Likewise, the
differences between patients with or without papilledema
were evaluated. Variables analysed included OFC growth
curve deflection, the presence of venous collaterals, and the
aspect of the transverse sinuses (see ‘Neuroimaging’). SPSS
statistics version 25 (IBM Corp., Armonk, NY, USA) was
used to perform the analyses, and statistical significance
was set at a p<0.05.
Ophthalmological evaluation
Visual acuity testing was routinely performed by an orthop-
tist, and was assessed by using either a Snellen/Tumbling E-
chart or the Amsterdam Picture Chart. Children who were
too young to be evaluated for visual acuity completed the
fix-and-follow test. The latest available test results were eval-
uated, since papilledema may have a long-term effect on
vision.13 Confounding caused by strabismus and/or ambly-
opia was minimalized by using the eye with the best visual
acuity. Results were expressed using the logMAR scale.
Cycloplegic refraction was measured and classified
according to the classification criteria described by Morgan
et al.:16 highly myopic: up to –6.00D; myopic: up to
–0.50D to greater than –6.00D; emmetropic: greater than
–0.50D to up to 0.50D; mildly hyperopic: greater than
0.50D to up to 2.00D; hyperopic: greater than 2.00D to
up to 6.00D; and highly hyperopic: greater than 6.00D.
Refraction was analysed at two time points: in children
aged up to 6 years old, when patients are at risk of devel-
oping ICH17 (at this age, refraction data were used to
interpret fundoscopy results, since hyperopia at least 3.00D
can mimic papilledema on fundoscopy12), and at the age of
at least 8 years old, since visual development continues up
until 7 to 8 years of age.18
Neuropsychological functioning
Educational levels were monitored at follow-up visits to
the outpatient clinic and used as a proxy for neuropsycho-
logical development.
Speech and language development
Speech and language development was routinely moni-
tored, and patients were referred for speech therapy if indi-
cated.
Approval and consent
This study was approved by the ethics committee of the
Erasmus MC (MEC-2005-273 and 2017-1143). Patient
consent was not required for this study.
RESULTS
Patient characteristics
We included 32 patients (21 females, 11 males). The med-
ian (SD) age at first surgery was 10.1 months (33.4mo) for
the whole group (range 3.6mo–14y 3mo), while it was 9.6
months (3.1mo) for patients primarily referred to our cen-
tre (range 3.6–13.0mo). See Table S1 (online supporting
information) for details. The median (SD) age at last fol-
low-up was 13 years (5y 6mo; range: 3–25y). Sixteen
patients had bicoronal synostosis, 10 had unicoronal synos-
tosis, and more than two sutures were closed in six patients
(Table S1). Five patients were excluded because of unavail-
able data.
The diagnosis was genetically confirmed in all patients
(Table S1). A TWIST1 gene mutation was identified in 21
patients (substitution n=16, duplication n=4, and insertion
n=1), and a deletion in or of the TWIST1 gene was identi-
fied in 11 patients. Two of the substitutions were familial
unclassified variants, and family members of these patients
had a Saethre–Chotzen-like phenotype. Both patients were
tested for the P250R mutation in the FGFR3 gene but it
was not found.
Thirty patients were treated according to our manage-
ment protocol. Twenty-four patients underwent cranial
vault surgery once, while second vault expansion was indi-
cated in six. Two patients underwent a third cranial vault
expansion in our centre after referral from elsewhere.
ICH
Bulging of the fontanel
There were no infants with bulging of the fontanel.
Symptoms
Thirteen patients had a headache episode, which for two
patients was related to ICH because of late referral (patient
numbers 22 and 25, Table S1). In the other 11 patients,
additional examinations such as fundoscopy, OCT scans,
polysomnography, and CT/MRI did not show abnormali-
ties, and the headaches resolved with expectant care. Beha-
vioural changes were not reported.
Skull growth
Nineteen patients had an OFC growth curve deflection
once or more during their lifetime, seven of whom had
papilledema in their medical histories (see Fig. S1, online
supporting information, for OFC growth curve trajectories
in patients with vs without papilledema). Five patients
showed an OFC growth curve deflection solely before first
surgery, whereas a deflection occurred in 12 out of 32
patients after first surgery, and in six out of the eight
patients after second skull surgery. The mean OFC in SD
before first surgery was –1.59 (range: –5.05 to 0.33).
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Fundoscopy
Seven patients had bilateral papilledema preoperatively,
which recurred in two patients during follow-up after first
surgery. Two patients solely had papilledema during fol-
low-up after first surgery. Two patients had recurring
papilledema after two routine cranial vault expansions else-
where (first surgery FOA and second surgery occipital
expansion) (see also Table S1 for detailed information on
these patients: numbers 29 and 30).
OCT
Nine patients underwent OCT, two of whom had
increased total retinal thickness at the ages of 5 and 8
years. In both patients, papilledema was also noted with
fundoscopy. Total retinal thickness was normal in the
other seven patients (i.e. no atrophy/papilledema).
Neuroimaging
The lateral ventricles were evaluated on 56 scans (MRI
n=28 and CT n=28) from 30 patients. One patient had
ventriculomegaly and none developed hydrocephalus.
Eleven out of 24 scored patients had occipital emissary
veins. The transverse sinuses were normal in 11 patients,
while they were unilaterally hypoplastic in 10 and unilater-
ally absent in three.
Cerebellar tonsil position was measured on 34 scans in
25 patients (mean age: 6y 6mo and range: 1d–24y 2mo).
Four patients had mild tonsillar descent (16%), while one
had a Chiari type I malformation (4%).
The seven patients who did not undergo MRI either had
dental braces (n=3) or the parents/patient did not consent
to MRI (n=4). See Table S1 for outcomes of neuroimag-
ing.
OSA
Twenty-two patients underwent a polysomnography, four
of whom had OSA (two mild, one moderate, and one sev-
ere) (Table S1). Polysomnography was performed routinely
in the two patients with mild OSA, whereas OSA was indi-
cated in the other two patients because of snoring/sleep
problems. One of the latter two patients was measured
clinically, while the other one was ambulant because of the
parents’ preference. Cheyne Stokes breathing patterns were
not detected in our cohort.
Coherence of risk factors for and symptoms of ICH
Patients with cranial vault surgery: single cranial vault
expansion versus expansion at least twice
Eight patients required a second cranial vault expansion.
Six were treated according to our management protocol.
Cranial vault surgery was indicated by papilledema in
one patient, whereas two patients had severe impressions
on X-ray imaging of the skull, indicating craniocerebral
disproportion. Three patients had both papilledema and
impressions/obliterated subarachnoid space on the CT
scan (i.e. signs of craniocerebral disproportion).
Preoperatively, OFC deflection was present in five
patients and one patient had moderate OSA due to choa-
nal atresia. Emissary veins were seen in three patients,
while the transverse sinus was aberrant in four (two
patients did not undergo CT angiography/MRI before
second vault expansion). Two patients underwent a rou-
tine two-stage procedure elsewhere: FOA first, followed
by occipital expansion. They both had papilledema at the
primary visit to our centre, for which we performed a
third cranial vault expansion (occipital expansion). Before
surgery, one of them had a deflecting OFC growth curve
while the other had no risk factors for ICH (i.e. OSA,
OFC deflection, or hydrocephalus). Collaterals were seen
in one, while both had an abnormal transverse sinus.
For an overview of proportions in patients who under-
went surgery twice or more versus one, see Table 1.
Patients with papilledema versus no papilledema
Of all nine patients with papilledema who were treated
according to our protocol, five had an OFC deflection
before they showed papilledema on fundoscopy. Occipital
collaterals were present in five out of eight patients
assessed (one did not undergo CT angiography/MRI
before/during the papilledema episode), while the trans-
verse sinus was aberrant in seven out of eight patients.
Transverse sinus anomalies were significantly more preva-
lent in patients with versus without papilledema (p=0.01,
Table 2).
Patients with tonsillar descent/Chiari type I malformation
Four out of the five patients with mild tonsillar descent
never had papilledema. Three patients had an OFC growth
curve deflection before first surgery (patient numbers 14,
16, and 32; Table S1). One had an OFC deflection before
first and second surgery (patient number 31; Table S1),
Table 1: Factors influencing proportional differences between the num-
ber of cranial vault expansions
Patients
undergoing 1
cranial vault
expansion (n)
Patients
undergoing ≥2
cranial vault
expansions (n) pa
OFC growth curve deflectionb
Yes 7 5 0.03
No 17 1c
Venous hypertension
Emissary veins
Yes 6 3 0.17
No 12 1
Transverse sinus hypoplastic/aplastic
Yes 7 4 0.045
No 11 0
The two patients who were not primarily referred to our centre
were left out of the analysis. aFisher’s exact test, one-tailed p-val-
ues (left side). bOFC deflection was scored ‘ever’ after first surgery
in patients who underwent cranial vault expansion once, and
before second cranial vault expansion in patients who underwent
cranial vault expansion at least two times. cImpressions on X-ray
skull and computed topography images at the age of 2 years 1
month. OFC, occipital frontal head circumference.
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and at that time papilledema was also noted on fun-
doscopy. One patient with mild tonsillar descent under-
went MRI repeatedly (patient number 14; Table S1). Mild
tonsillar descent was diagnosed at the age of 15 years 8
months, while it was absent on three previous MRI scans
between the ages of 7 years 10 months and 10 years 4
months.
Ophthalmological evaluation
Visual acuity was evaluated in 22 patients, with the mean
age at evaluation 9 years 7 months (range: 3y 6mo–24y
10mo; see Table S1). Ptosis of the upper eyelid was estab-
lished in 14 patients, which was bilateral in five cases.
Sixteen patients had their cycloplegic refraction analysed
at the age of at least 8 years. One patient had emmetropia
and one was diagnosed with myopia. Six patients had mild
hyperopia, seven patients had hyperopia, and one patient
had high hyperopia.
Neuropsychological functioning
Twenty-four children went to a normal school. Three chil-
dren followed an individualized curriculum at a specialist
school, all because of intellectual disability (mild in one).
Three patients were in nursery school. Information regard-
ing educational level was missing for two patients.
Speech and language development
Twelve patients were referred to a speech therapist because
of a speech and language delay, seven of whom had hear-
ing loss. Two patients had intellectual disability, which was
presumably related to the whole-gene deletion. Two other
patients were assumed to have a delay because they were
bilingual, and one had an overall motor development delay
causing speech problems. Data regarding referral were
lacking for seven patients and consecutive speech reports
were not available for the whole cohort.
DISCUSSION
In this study, we evaluated the outcomes of our standard
management protocol for patients with Saethre–Chotzen
syndrome: a single FOA. A second cranial vault expansion
because of ICH was indicated for only six out of 30 patients
treated according to our protocol, while both patients who
were treated with routine two-stage cranial vault expansion
elsewhere required a third procedure. The risk factors for
ICH in craniosynostosis syndromes include craniocerebral
disproportion, venous outflow obstruction, moderate or sev-
ere OSA, and hydrocephalus.17,19 In our cohort, OFC
deflection after the first surgery occurred in 13 out of 32
patients, venous abnormalities in 17 out of 24, only one had
ventriculomegaly, none had hydrocephalus, and moderate-
to-severe OSA was detected in two out of 22. Of the six
patients who underwent second surgery, five out of six had
an OFC deflection, four out of four had venous abnormali-
ties, one out of five had ventriculomegaly, and one out of
three had moderate-to-severe OSA. Hence, craniocerebral
disproportion (e.g. OFC deflection) and venous outflow
obstruction due to an aberrant transverse sinus seem to be
the main risk factors for ICH in patients with Saethre–Chot-
zen syndrome during follow-up. In contrast, moderate-to-
severe OSA occurs less often than in other craniosynostosis
syndromes, and polysomnographies should only be per-
formed in case of anamnestic breathing difficulties. When-
ever mild OSA is diagnosed, expectant care is advised
(unpublished material, de Goederen et al.). In case of moder-
ate-to-severe OSA, an adenotonsillectomy should be consid-
ered (unpublished material, de Goederen et al.).
The presence of venous anomalies in the majority of
patients with Saethre–Chotzen syndrome could be related
to the TWIST1 gene mutation, since this mutation is
involved in the development of vascular malformations of
cerebral veins.20 Venous anomalies such as an aberrant
transverse sinus can limit the cerebral venous outflow as
they result in abnormal venous drainage. After venous out-
flow obstruction, the increased hydrostatic pressure within
the sinuses may eventually lead to ICH as it impairs the
resorption of cerebrospinal fluid.21,22 Emissary veins or
venous collaterals have been regarded as an alternative
venous pathway, and thus a compensation mechanism, for
ICH by others.19,21—23 The absence of a significant corre-
lation between papilledema and emissary veins in our series
might be correlated with the functional efficiency of these
collateral veins.21 Likewise, this finding highlights the pres-
ence of a complex interaction between causative factors for
ICH in syndromic craniosynostosis.
A routine one-stage procedure seems to be sufficient to
prevent ICH for the majority of the patients with Saethre–
Chotzen syndrome. Therefore, we recommend a one-stage
FOA for such patients. Whenever a second cranial vault
surgery is indicated, occipital expansion or FOA should be
performed, depending on the patients’ phenotype.
Tonsillar herniation occurred in five patients. Four of
these patients had an OFC deflection preoperatively;
Table 2: Factors influencing proportional differences between patients
with and without papilledema
Patients
with
papilledema
Patients
without
papilledema pa
OFC growth curve deflectionb
Yes 5 11 0.60
No 4 10
Venous hypertension
Emissary veins
Yes 5 4 0.13
No 3 10
Transverse sinus hypoplastic/aplastic
Yes 7 4 0.01
No 1 10
The two patients who were not primarily referred to our centre
were left out of this analysis. aFisher’s exact test, one sided p-value
(right side). bThe existence of OFC deflection was scored as either
before the development of papilledema or ‘ever’ in patients who
never developed papilledema. OFC, occipital frontal head circum-
ference.
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however, only one developed papilledema. Moreover, none
developed hydrocephalus and only one had ventricu-
lomegaly, both of which are closely related to the mild
tonsillar descent/Chiari type I malformation seen in Apert
and Crouzon syndromes.24 In a previous study, a normal
volume of the cerebellum and posterior fossa was found in
patients with Saethre–Chotzen syndrome25 while brain vol-
ume was normal.24 The mild herniation of cerebellar ton-
sils in these patients appears to be a result of restricted
intracranial volume, and it appears to offer sufficient com-
pensation to prevent progression into ICH. Additionally,
the fact that eight out of the 12 patients with an OFC
deflection did not develop tonsillar herniation matches the
relatively mild impact of impaired skull growth in Saethre–
Chotzen syndrome. MRI analysis of adult patients with
Saethre–Chotzen syndrome would be valuable for further
research, since the mean age at MRI was 6 years in our
population and tonsil position is known to descend
between the ages of 0 to 20 years.26
Comparing our Saethre–Chotzen cohort to those with
other craniosynostosis syndromes, the prevalence of papil-
ledema in this study seems to be higher than in patients
with Muenke syndrome (23% vs 8% respectively).10 This
difference in prevalence might be caused by the absence of
the four causative factors for ICH in Muenke syndrome.10
In contrast, patients with Apert and Crouzon syndromes
develop signs of ICH more frequently, which is probably
caused by the higher prevalence of moderate-to-severe
OSA, OFC deflection, and ventriculomegaly/hydrocephalus
in these patients,7,8,17,24,27,28 whereas the counts of venous
anomalies in Apert and Crouzon syndromes seem to be
comparable with Saethre–Chotzen syndrome.22,23,29,30
As with all investigations, this study has some limita-
tions. First, the number of patients in this study prevented
a trustworthy logistic regression model from being per-
formed because of the small number of cases. With a lar-
ger sample size, a complete statistical model with all
potential risk factors for ICH could be developed, and the
precise contribution of these factors would be better clari-
fied. Therefore, for future research purposes, a multicentre
cohort study would be preferable. Second, patients under-
went surgery performed by four different surgeons, which
could potentially result in surgeon variability. However, we
think that the influence of inter-surgeon variability was
limited in our population because the surgical procedures
performed were practically identical. Last, three out of the
32 patients were below the age of 6 years at the last fol-
low-up, and were thus not followed up until skeletal matu-
rity. Consequently, the reoperation rate that we recorded
represents the lower bound, and is likely to vary between
20% to 30% (six out of 30 vs nine out of 30 patients who
were treated according to the protocol).
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